EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

High PD-L1 Expression in HRS Cells and Macrophages in Tumor Immune Microenvironment Is Associated with Adverse Outcome and EBV Positivity in Classical Hodgkin Lymphoma

Antonija Miljak, Antonia Pavlović, Benjamin Benzon iD, Lučana Vicelić Čutura, Davor Galušić, Milan Vujčić iD, Viktor Blaslov, Merica Glavina Durdov

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26125592 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Antonija Miljak und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Division of Haematology, University Hospital of Split, 21000 Split, Croatia. Hauptthemen laut MEDLINE: B7-H1 Antigen, Hodgkin Disease, Tumor Microenvironment, Macrophages. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Programmed death-ligand 1 (PD-L1) on tumor cells, including Hodgkin and Reed–Sternberg (HRS) cells in classical Hodgkin’s lymphoma (cHL), suppresses immune responses in the tumor immune microenvironment (TME). We analyzed PD-L1 expression in macrophages and HRS cells of 98 cHL cases and correlated the findings with clinicopathological features, overall survival (OS), and progression-free survival (PFS). Epstein–Barr virus (EBV) was detected by in situ hybridization for EBV-encoded RNA. Ten high-power fields were evaluated to count the total number of macrophages and PD-L1+ macrophages, and to calculate PD-L1 histoscore (H-score) in HRS cells. EBV-positive cHL was found in 22.5% of patients. The median H-score was 80 (range 0–300). Bulky disease was associated with a lower number of PD-L1+ macrophages, and extranodal disease with a higher number (p = 0.05). EBV-positive cHL showed a higher PD-L1 H-score in HRS cells and a greater number of PD-L1+ macrophages (p = 0.005); both of these features, along with the proportion of PD-L1+ macrophages, were associated with shorter PFS and OS (p < 0.001). High PD-L1 expression in HRS and macrophages may be linked to worse clinical outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

B7-H1 AntigenHodgkin DiseaseTumor MicroenvironmentMacrophagesHerpesvirus 4, HumanEpstein-Barr Virus InfectionsReed-Sternberg CellsHumansMaleFemaleAdultMiddle AgedAdolescentYoung AdultAgedPrognosis

Stichwörter der Autor:innen

EBVHRSHodgkin lymphomaPD-L1macrophageoutcome

Substanzen

B7-H1 AntigenCD274 protein, human

Autor:innen und Institutionen

  • Department of Internal Medicine, Division of Haematology, University Hospital of Split, 21000 Split, Croatia.
  • Department of Pathology, Forensic Medicine and Cytology, University Hospital of Split, 21000 Split, Croatia.
  • School of Medicine, University of Split, 21000 Split, Croatia.

ORCID-Profile: Benjamin Benzon, Milan Vujčić

Zitieren

APA

Miljak, A., Pavlović, A., Benzon, B., Čutura, L. V., Galušić, D., Vujčić, M., Blaslov, V., & Durdov, M. G. (2025). High PD-L1 Expression in HRS Cells and Macrophages in Tumor Immune Microenvironment Is Associated with Adverse Outcome and EBV Positivity in Classical Hodgkin Lymphoma. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26125592

Vancouver

Miljak A, Pavlović A, Benzon B, Čutura LV, Galušić D, Vujčić M, et al. High PD-L1 Expression in HRS Cells and Macrophages in Tumor Immune Microenvironment Is Associated with Adverse Outcome and EBV Positivity in Classical Hodgkin Lymphoma. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26125592

BibTeX
@article{Miljak2025,
  author = {Miljak, Antonija and Pavlović, Antonia and Benzon, Benjamin and Čutura, Lučana Vicelić and Galušić, Davor and Vujčić, Milan and Blaslov, Viktor and Durdov, Merica Glavina},
  title = {High PD-L1 Expression in HRS Cells and Macrophages in Tumor Immune Microenvironment Is Associated with Adverse Outcome and EBV Positivity in Classical Hodgkin Lymphoma},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26125592}
}
Kostenlos starten →